Incyte Corporation Price Today
Incyte Corporation
INCY
Healthcare
$11.77B
💰
Market Cap
32.2
💸
Price to Earnings
$1.6
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
9 |
Strong Buy |
6 |
Hold |
11 |
Sell |
0 |
Strong Sell |
0 |
INCY Price Forecast Target
52.5 👉 114.0 +117%
INCY EPS Forecast
1.6 👉 4.6 +182%
Financials
Profit Margin
10 %
Revenue Growth
4.7 %
Dividend
$ 0
Held Percent
1.4% - Insiders
99.4% - Institutions
-0.8% - Public
Major Fund Holders
-
💰 Baker Brothers Advisors, LLC $2.3B
-
💰 Blackrock Inc. $1.5B
-
💰 Vanguard Group Inc $1.4B
-
💰 Dodge & Cox Inc $1.2B
-
💰 State Street Corporation $613.2M
Stock Ideas
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples a…
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.
Ray Dalio Portfolio
Ray Dalio, a visionary entrepreneur and investment strategist, laid the foundation of Bridgewater with a clear vision in mind. His relentless pursuit of excellence, coupled with an unwavering commitment to innovation, has propelled Bridgewater to be…
David Tepper Portfolio
David Tepper is a renowned billionaire investor, widely known for his incredible success during the 2009 financial crisis where he made a staggering $4 billion. His financial prowess has earned him the distinction of being the 258th richest individ…📮FAQ
Some Frequently Asked Questions.
The Incyte Corporation industry is Biotechnology
The Incyte Corporation sector is Healthcare
The Incyte Corporation forecasted predicted Price to Earnings PE ratio is 11.4
The Incyte Corporation Price to Earnings PE ratio is 32.2
The Market Capitalization of Incyte Corporation is $11.77B
There are total of 186620232 float shares with 99.4% held by Institutions and 1.4% held by insiders
The MIncyte Corporation forecasted Earnings per Share EPS is $4.6
The Incyte Corporation Earnings per Share EPS is 1.6
The Incyte Corporation company has $1593729000 gross profits with 10 profit margins
The Incyte Corporation Earnings Growth is 0.25% with 0.261% quarterly earnings growth
The Incyte Corporation Revenue is $3513285888 with 0.047 revenue growth
The price target for Incyte Corporation stock is $114.0 for the high target and $58.0 for the low target
The consensus analyst recommendations for Incyte Corporation is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Incyte Corporation is Buy, with the following breakdown:
- Buy: 9
- Strong Buy: 6
- Hold: 11
- Sell: 0
- Strong Sell: 0
The Beta of Incyte Corporation is 0.7
The dividend of Incyte Corporation is $0
The dividend yield of Incyte Corporation is 0.0058999998%
The biggest institutional and mutual fund holders of Incyte Corporation stock are
- Baker Brothers Advisors, LLC
- Blackrock Inc.
- Vanguard Group Inc
- Dodge & Cox Inc
The Incyte Corporation ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0